Products Categories
CAS No.: | 58-61-7 |
---|---|
Name: | Adenosine |
Article Data: | 329 |
Cas Database | |
Molecular Structure: | |
|
|
Formula: | C10H13N5O4 |
Molecular Weight: | 267.244 |
Synonyms: | Adenosine(AR);Adenocor;9-beta-D-Ribofuranosyl-9H-purin-6-amine;(3R,4R,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;9H-Purin-6-amine, 9beta-D-ribofuranosyl-;Sandesin;Usaf cb-10;Myocol;.beta.-Adenosine;Adenosin [German];Boniton;Adenoside;9-β-D-Ribofuranosyladenine;.beta.-D-Ribofuranoside, adenine-9;.beta.-D-Adenosine;Adenocard;46969-16-8;beta-Adenosine;Adrekar;SR 96225;adenine-D-ribose;Adenosine [USAN:BAN];9.beta.-D-Ribofuranosyladenine;6-Amino-9.beta.-D-ribofuranosyl-9H-purine;adenine-9;Riboadenosine;D-Adenosine;Nucleocardyl;beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-;46946-45-6;Adenine nucleoside;(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;6-Amino-9-.beta.-ribofuranosyl-9H-purine;4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside;9-beta-D-Ribofuranosyladenine;Adenosine (8CI,9CI);Adenine riboside; |
EINECS: | 200-389-9 |
Density: | 2.08 g/cm3 |
Melting Point: | 234-236 °C(lit.) |
Boiling Point: | 676.3 °C at 760 mmHg |
Flash Point: | 362.8 °C |
Solubility: | Soluble in water, ammonium hydroxide and dimethyl sulfoxide. Insoluble in ethanol. |
Appearance: | white crystalline powder |
Risk Codes: | 36/37/38 |
Safety: | 24/25 |
PSA: | 139.54000 |
LogP: | -1.39880 |
(2R,3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-4-(benzyloxy)-5-(hydroxymethyl) tetrahydrofuran-3-ol
adenosine
Conditions | Yield |
---|---|
With hydrogen; palladium on activated charcoal In ethanol at 50℃; | 100% |
Conditions | Yield |
---|---|
With lipase A from Aspergillus niger In aq. phosphate buffer; acetonitrile at 25℃; for 0.5h; pH=7; Enzymatic reaction; | 99% |
With ammonia at 25℃; | 83% |
With methanol; ammonia |
3',5'-O-(1,1,3,3-tetra-isopropyldisiloxane-1,3-diyl)adenosine
adenosine
Conditions | Yield |
---|---|
With ammonium fluoride In methanol at 60℃; for 3h; | 99% |
With ammonium fluoride In methanol at 60℃; for 3h; other silyl ethers; | 99% |
Conditions | Yield |
---|---|
In 1,4-dioxane for 1.5h; Product distribution; Mechanism; Ambient temperature; | A 93% B 99% |
5'-O-(p-methoxyphenyldiphenylmethyl)adenosine
adenosine
Conditions | Yield |
---|---|
With ammonium cerium(IV) nitrate; silica gel In dichloromethane at 25℃; for 0.1h; detritylation; | 98% |
With hydrogenchloride In water; acetonitrile at 60℃; for 0.25h; pH=Ca. 1; Inert atmosphere; | 63 mg |
Conditions | Yield |
---|---|
With benzophenone; Selectfluor In water; acetonitrile for 5h; Reagent/catalyst; Inert atmosphere; UV-irradiation; | 97% |
With Selectfluor; riboflavin In water; acetonitrile at 37℃; under 760.051 Torr; for 2h; Reagent/catalyst; Inert atmosphere; Irradiation; | 86% |
With manganese(IV) oxide; C17H20N4O9P(1-)*Na(1+); oxygen In water; acetonitrile at 20℃; under 760.051 Torr; for 7h; Mechanism; Kinetics; Reagent/catalyst; Irradiation; chemoselective reaction; | 79% |
With dihydrogen peroxide; ammonium bicarbonate at 37℃; for 24h; |
5'-O-(triphenylmethyl)adenosine
adenosine
Conditions | Yield |
---|---|
With ammonium cerium(IV) nitrate; silica gel In dichloromethane at 25℃; for 1.5h; detritylation; | 95% |
With cerium(IV) triflate; water In acetonitrile at 25℃; for 1.5h; | 88% |
With chlorine In chloroform at 4℃; for 0.5h; | 85% |
With sulfuric acid; water; silica gel In acetonitrile at 25℃; for 0.283333h; | 82% |
With trifluoroacetic acid In water; acetonitrile at 0 - 20℃; for 12h; | 36 mg |
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((4-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
adenosine
Conditions | Yield |
---|---|
With ammonium peroxydisulfate; phosphate buffer at 80℃; for 2h; | 95% |
5'-O-dimethoxytrityladenosine
adenosine
Conditions | Yield |
---|---|
With K 10 clay In methanol; water for 20h; Ambient temperature; | 95% |
With cerium(IV) triflate; water In acetonitrile at 25℃; for 0.75h; | 95% |
With 1,1,1,3',3',3'-hexafluoro-propanol for 1h; Ambient temperature; | 87 % Turnov. |
Multi-step reaction with 6 steps 1: Et3N; DMAP / CH2Cl2 2: dichloroacetic acid; pyrrole / CH2Cl2 3: 87 percent / 2,4,6-triisopropylbenzenesulfonyl chloride; 3-nitro-1,2,4-1H-triazole; pyridine / 1 h / 20 °C 4: Me3SiCl / acetonitrile / 6 h / 60 °C 5: 0.060 g / aq. NH3 / acetonitrile / 0.08 h / 20 °C 6: CD3CO2D; D2O / 23 °C View Scheme |
Conditions | Yield |
---|---|
With tris-(trimethylsilyl)silane; 2-hydroxyethanethiol In water at 100℃; for 4h; | 94% |
With potassium fluoride; N,O-bis-(trimethylsilyl)-acetamide; perhydrodibenzo-18-crown-6 In acetonitrile for 96h; Heating; | 36% |
With tris-(trimethylsilyl)silane; 2-hydroxyethanethiol; 1,1'-azobis(1-cyanocyclohexanenitrile); triethylamine In water at 100℃; for 1h; | 94 % Turnov. |
Multi-step reaction with 2 steps 1.1: H2SO4; NaNO2; KBr / 3 h / -15 - 20 °C 1.2: H2O / 65 °C 1.3: 0.14 g / aq. NaOH / dimethylsulfoxide / 5 h 2.1: UV-irradiation View Scheme | |
Multi-step reaction with 3 steps 1: pyridine / 0.5 h 2: sodium naphthalenide / tetrahydrofuran / -60 °C 3: aq. NH3 / methanol / 0.5 h View Scheme |
Adenosine (CAS NO.58-61-7) is reported in EPA TSCA Inventory.
The Adenosine, with the CAS registry number 58-61-7, is also known as 9H-Purin-6-amine, 9beta-D-ribofuranosyl-. It belongs to the product categories of Pharmaceutical Intermediates; Fine Chemical & Intermediates; Purine; API intermediates; Nucleosides and their analogs; Biochemistry; Nucleosides, Nucleotides & Related Reagents; Nucleic acids. Its EINECS registry number is 200-389-9. This chemical's molecular formula is C10H13N5O4 and molecular weight is 267.24. Its IUPAC name is called (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol. This chemical's classification codes are Analgesics; Anti-arrhythmia agents; Cardiac depressant [anti-arrhythmic]; Cardiovascular agents; Central Nervous System Agents; Drug / Therapeutic Agent; Human Data; Mutation data; Peripheral Nervous System Agents; Sensory System Agents; Vasodilator agents. When you are using this chemical, please be cautious about it. You must avoid contacting it with skin and eyes.
Physical properties of Adenosine: (1)# of Rule of 5 Violations: 1; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 8.94; (5)ACD/KOC (pH 7.4): 9.254; (6)#H bond acceptors: 9; (7)#H bond donors: 5; (8)#Freely Rotating Bonds: 5; (9)Index of Refraction: 1.907; (10)Molar Refractivity: 59.959 cm3; (11)Molar Volume: 128.164 cm3; (12)Surface Tension: 107.624 dyne/cm; (13)Density: 2.085 g/cm3; (14)Flash Point: 362.796 °C; (15)Enthalpy of Vaporization: 104.298 kJ/mol; (16)Boiling Point: 676.271 °C at 760 mmHg; (17)Vapour Pressure: 0 mmHg at 25°C.
Preparation: Adenosine can be prepared by O2',O3',O5'-triacetyl-adenosine. This reaction will need reagent methanol and NH3.
Uses of Adenosine: it can be used to produce O2'-methyl-adenosine. This reaction will need reagent aqueous 1,2-dimethoxy-ethane.
Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety via a β-N9-glycosidic bond. Adenosine is an endogenous purine nucleoside that modulates many physiological processes. Adenosine plays an important role in biochemical processes, such as energy transfer—as adenosine triphosphate (ATP) and adenosine diphosphate (ADP)—as well as in signal transduction as cyclic adenosine monophosphate, cAMP.
You can still convert the following datas into molecular structure:
(1)SMILES:c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N;
(2)Std. InChI:InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1;
(3)Std. InChIKey:OIRDTQYFTABQOQ-KQYNXXCUSA-N;
The toxicity data is of Adenosine as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | intravenous | 50ug/kg/1M-I (0.05mg/kg) | LUNGS, THORAX, OR RESPIRATION: BRONCHIOLAR CONSTRICTION | Human & Experimental Toxicology. Vol. 13, Pg. 263, 1994. |
man | TDLo | intravenous | 143ug/kg/I (0.143mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: HEADACHE | Medical Journal of Australia. |
man | TDLo | intravenous | 171ug/kg (0.171mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA CARDIAC: PULSE RATE | American Journal of Emergency Medicine. Vol. 11, Pg. 192, 1993. |
man | TDLo | intravenous | 257ug/kg (0.257mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP LUNGS, THORAX, OR RESPIRATION: CYANOSIS | American Journal of Emergency Medicine. Vol. 11, Pg. 249, 1993. |
man | TDLo | intravenous | 257ug/kg/1D-I (0.257mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION CARDIAC: CHANGE IN RATE | Annals of Internal Medicine. Vol. 122, Pg. 351, 1995. |
mouse | LD50 | intraperitoneal | 500mg/kg (500mg/kg) | National Technical Information Service. Vol. AD277-689, | |
mouse | LD50 | oral | > 20gm/kg (20000mg/kg) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 45, 1980. | |
women | TDLo | intravenous | 240ug/kg (0.24mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | American Journal of Emergency Medicine. Vol. 14, Pg. 300, 1996. |
women | TDLo | intravenous | 360ug/kg/1H-I (0.36mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP CARDIAC: CHANGE IN RATE | American Journal of Emergency Medicine. Vol. 10, Pg. 326, 1992. |